Drug Information Association Logo

Program Committee

Programme Chair

Janet Davies, Director, International Medical Information and Medical Affairs Project Management, Gilead Sciences, UK

THEME 1 | PATIENTS

Jan Geissler, EUPATI & Patvocates, Germany

Detlef Niese, Head, Development External Affairs, Novartis Pharma AG, Switzerland

THEME 2 | CLINICAL RESEARCH


Holger Maria Rohde, Head of Preclinical & Medical Affairs, Pharmalex GmbH, Germany

THEME 3 | CLINICAL OPERATIONS

Estrella García, Head of Global Clinical Operations, Almirall S.A., Spain

Nermeen Varawalla, President and CEO, ECCRO, UK

THEME 4 | DRUG SAFETY AND RISK MANAGEMENT

Mariska Kooijmans-Coutinho, Vice President Safety and Benefit-Risk Management and EU QPPV, Biogen Idec Ltd, UK

Maarten Lagendijk, Pharmacovigilance Coordinator, Medicines Evaluation Board (CBG-MEB), Netherlands

Monika Pietrek, Managing Director, Pietrek Associates GmbH, Germany

THEME 5 | PERI- AND POST-APPROVAL STUDIES

Paul Jäkel, Head of Global Non-Interventional Studies, Bayer Pharma AG, Germany

Heike Schön, Managing Director, CSG Clinische Studien GmbH, Germany

THEME 6 | MEDICAL INFORMATION AND COMMUNICATIONS

Lillian Auberson, Head Global Medical Information, Actelion Pharmaceuticals Ltd, Switzerland

Aaron Cockell, Regional Director, Medical Information, EMEA Pfizer Inc., UK

THEME 7 | eCLINICAL/CDM

Valdo Arnera, General Manager Europe, PHT Corporation, Switzerland

Julianne Hull, CEO, WenStar Enterprises, UK

Pierre-Yves Lastic, Senior Director, Data Privacy & Healthcare Interoperability Standards, Sanofi, France

Detlef Nehrdich, Senior Associate, Waife & Associates, Germany

THEME 8 | VALIDATION

Rolf Banholzer, Global Head CQA Computerized System Services Novartis Pharma AG, Switzerland

Breffni Martin, Director, Optuminsight Strategic Regulatory Services, Ireland
© 2014 DIA